Over 100 California Auctions End Today - Bid Now
Over 1850 Total Lots Up For Auction at Two Locations - TN 02/23, NJ Cleansweep 02/29

Siemens Healthineers lays out cost-cutting strategy ahead of IPO

by Thomas Dworetzky, Contributing Reporter | January 16, 2018

Some of the trends driving this increase include the growing and aging populations, a rise in the care of chronic diseases, and better access to care in emerging markets.

“Given that health care productivity has historically lagged behind that of other industries, horizontal and vertical consolidation is progressing in the industry, and governments and insurers are changing financial incentive systems to transform health care delivery from volume to value,” according to the company.

This is coupled with the increasing precision of treatments and a growth in accessibility and patient empowerment.

“These changes are being accelerated by digitalization and the use of artificial intelligence,” it advised, adding that big data is playing a major role in these shifts and is “becoming a source of value creation in the sector.”

The Healthineers are industry leaders in imaging, the company's largest source of revenue, which accounted for €8.2 billion of income in fiscal 2017.

Diagnostics accounted for €4.2 billion of revenue in fiscal 2017. Estimates are for 5 percent annual growth from 2016 to 2021.

The recent launch of Atellica Solution, “holds great potential for becoming one of the company's future growth and profitability engines,” according to the company. Atellica Solution is able to run up to 440 tests per hour, and of transport samples up to ten times faster than conventional conveyers.

Another source of growing revenue is Advanced Therapies – which the company called “the forefront of the paradigm shift in health care, particularly in transforming surgery toward minimally-invasive procedures empowered by image-guided therapy.”

The Healthineers will continue to focus in five specific areas – maximizing its position in the in-vivo and in-vitro markets to further precision medicine, data and AI efforts to integrate and innovate therapy technologies, optimizing patient experience throughout the health care process, developing a “full range” of technical, operational and clinical service offerings, and a continued push into the application of AI into these areas.

Back to HCB News

You Must Be Logged In To Post A Comment